Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy

Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy

Abstract Tumor treatment is still complicated in the field of medicine. Tumor immunotherapy has been the most interesting research field in cancer therapy. Application of chimeric antigen receptor T (CAR-T) cell therapy has recently achieved excellent clinical outcome in patients, especially those w...

Full description

Bibliographic Details
Main Authors: Yanyu Pang, Xiaoyang Hou, Chunsheng Yang, Yanqun Liu, Guan Jiang
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Molecular Cancer
Subjects:
Chimeric antigen receptor T cells
Hematological malignancies
Acute lymphoblastic leukemia
Solid tumors
Cytokine release syndrome
Online Access:http://link.springer.com/article/10.1186/s12943-018-0840-y

Internet

http://link.springer.com/article/10.1186/s12943-018-0840-y

Similar Items